However, recent studies have found that IL-10 may exhibit pro-inflammatory properties and participate in disease progression under specific pathological conditions, such as in autoimmune diseases, malignant tumors, and coronavirus disease 2019 (COVID-19) infection (11, 12). This evidence concerns the gene IL10 and cancer.